Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate

被引:72
|
作者
Wang, Qi [1 ,2 ,3 ]
Vogan, Erik M. [4 ,5 ,6 ]
Nocka, Laura M. [7 ]
Rosen, Connor E. [1 ,2 ,3 ]
Zorn, Julie A. [1 ,2 ,3 ]
Harrison, Stephen C. [4 ,5 ,6 ]
Kuriyan, John [1 ,2 ,3 ,7 ,8 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA
[4] Boston Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[8] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phy Biosci Div, Berkeley, CA 94720 USA
来源
ELIFE | 2015年 / 4卷
关键词
CELL ANTIGEN RECEPTOR; ELECTRON-DENSITY MAPS; B-CELL; PH DOMAIN; CRYSTAL-STRUCTURE; SH3; DOMAIN; C-ABL; STRUCTURAL BASIS; PROTEIN; BINDING;
D O I
10.7554/eLife.06074
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bruton's tyrosine kinase (Btk), a Tec-family tyrosine kinase, is essential for B-cell function. We present crystallographic and biochemical analyses of Btk, which together reveal molecular details of its autoinhibition and activation. Autoinhibited Btk adopts a compact conformation like that of inactive c-Src and c-Abl. A lipid-binding PH-TH module, unique to Tec kinases, acts in conjunction with the SH2 and SH3 domains to stabilize the inactive conformation. In addition to the expected activation of Btk by membranes containing phosphatidylinositol triphosphate (PIP3), we found that inositol hexakisphosphate (IP6), a soluble signaling molecule found in both animal and plant cells, also activates Btk. This activation is a consequence of a transient PH-TH dimerization induced by IP6, which promotes transphosphorylation of the kinase domains. Sequence comparisons with other Tec-family kinases suggest that activation by IP6 is unique to Btk.
引用
收藏
页数:84
相关论文
共 50 条
  • [21] Involvement of Bruton's tyrosine kinase (BTK) in CD38-mediated B cell activation.
    Yasue, T
    Kikuchi, Y
    Nishizumi, H
    Miyake, K
    Yamamoto, T
    Takatsu, K
    FASEB JOURNAL, 1996, 10 (06): : 381 - 381
  • [22] Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors
    Tang, Chloe Pek Sang
    McMullen, Julie
    Tam, Constantine
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1554 - 1564
  • [23] Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases
    Shi, Qing
    Tebben, Andrew
    Dyckman, Alaric J.
    Li, Hedy
    Liu, Chunjian
    Lin, James
    Spergel, Steve
    Burke, James R.
    McIntyre, Kim W.
    Olini, Gilbert C.
    Strnad, Joann
    Surti, Neha
    Muckelbauer, Jodi K.
    Chang, Chiehying
    An, Yongmi
    Cheng, Lin
    Ruan, Qian
    Leftheris, Katerina
    Carter, Percy H.
    Tino, Joseph
    De Lucca, George V.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2206 - 2211
  • [24] Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
    Ariza, Yuko
    Murata, Masayuki
    Ueda, Yoshiko
    Yoshizawa, Toshio
    BONE REPORTS, 2019, 10
  • [25] Immunoprofiling of Bruton's Tyrosine Kinase (Btk)/Tec Family Kinase Inhibitors Indicate Activities Beyond Btk in Immunocyte Function
    Kosek, Jolanta
    Capone, Lori
    Adams, Mary
    Hur, Eun Mi
    Schafer, Peter H.
    Ringheim, Garth
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [26] Bruton's Tyrosine Kinase (BTK) Is a Novel KMT2A Partner Gene
    Zerkalenkova, Elena
    Lebedeva, Svetlana
    Soldatkina, Olga
    Maschan, Michael
    Maschan, Alexey A.
    Novichkova, Galina
    Olshanskaya, Yulia
    BLOOD, 2019, 134
  • [27] Design and synthesis of carbazole carboxamides as novel inhibitors of Bruton's tyrosine kinase (BTK)
    Liu, Qingjie
    Batt, Douglas G.
    Baldwin, Kathy F.
    Chang, ChiehYing
    Lippy, Jonathan S.
    Muckelbauer, Jodi K.
    Strnad, Joann
    Surti, Neha
    Tebben, Andrew J.
    Wang, Haiqing
    Yang, Zheng
    Fura, Aberra
    Burke, James R.
    Carter, Percy H.
    Tino, Joseph A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [28] Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein
    Weimin Liu
    Ileana Quinto
    Xueni Chen
    Camillo Palmieri
    Ronald L. Rabin
    Owen M. Schwartz
    David L Nelson
    Giuseppe Scala
    Nature Immunology, 2001, 2 : 939 - 946
  • [29] The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC)
    Chen, Jun
    Kinoshita, Taisei
    Gururaja, Tarikere
    Sukbuntherng, Juthamas
    James, Danelle
    Lu, Daniel
    Whang, Jennifer
    Versele, Matthias
    Chang, Betty Y.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (05) : 604 - 612
  • [30] Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia
    Ritis, K
    Speletas, M
    Tsironidou, V
    Pardali, E
    Kanariou, M
    Moschese, V
    Orlandi, P
    Skordala, M
    Rossi, P
    Kartalis, G
    Bourikas, G
    Sideras, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (05) : 1241 - 1248